HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.

Abstract
The eukaryotic green algae, Chlamydomonas reinhardtii has been shown to be capable of producing a variety of recombinant proteins, but the true potential of this platform remains largely unexplored. To assess the potential of algae for the production of novel recombinant proteins, we generated a series of chimeric proteins containing a single chain antibody (scFv) targeting the B-cell surface antigen CD22, genetically fused to the eukaryotic ribosome inactivating protein, gelonin, from Gelonium multiflorm. These unique molecules, termed immunotoxins, are encoded as a single gene that produces an antibody--toxin chimeric protein capable of delivering a cytotoxic molecule to targeted B-cells. We show that the addition of an Fc domain of a human IgG1 to these fusion proteins results in the production of assembled dimeric immunotoxins, containing two cell binding scFvs and two gelonin molecules. Additionally, we demonstrate that these algal expressed proteins are capable of binding and reducing the viability of B-cell lymphomas, while treatment of T-cells, that lack the CD22 antigen, had no impact on cell viability. Since other protein expression platforms are incapable of folding and accumulating these complex immunotoxins as soluble and enzymatically active proteins, our studies document a novel and efficient method for immunotoxin production.
AuthorsMiller Tran, Ryan E Henry, David Siefker, Christina Van, Greg Newkirk, Julie Kim, Jack Bui, Stephen P Mayfield
JournalBiotechnology and bioengineering (Biotechnol Bioeng) Vol. 110 Issue 11 Pg. 2826-35 (Nov 2013) ISSN: 1097-0290 [Electronic] United States
PMID23719862 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2013 Wiley Periodicals, Inc.
Chemical References
  • Antineoplastic Agents
  • CD22 protein, human
  • Immunoglobulin G
  • Immunotoxins
  • Recombinant Fusion Proteins
  • Ribosome Inactivating Proteins, Type 1
  • Sialic Acid Binding Ig-like Lectin 2
  • GEL protein, Gelonium multiflorum
  • Ribosome Inactivating Proteins
Topics
  • Antineoplastic Agents (metabolism)
  • B-Lymphocytes (drug effects, physiology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Chlamydomonas reinhardtii (genetics, metabolism)
  • Humans
  • Immunoglobulin G (genetics, metabolism)
  • Immunotoxins (genetics, metabolism)
  • Molecular Sequence Data
  • Recombinant Fusion Proteins (genetics, metabolism)
  • Ribosome Inactivating Proteins (genetics, metabolism)
  • Ribosome Inactivating Proteins, Type 1 (genetics, metabolism)
  • Sequence Analysis, DNA
  • Sialic Acid Binding Ig-like Lectin 2
  • T-Lymphocytes (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: